Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer. Cai Z, Chen H, Bai J, Zheng Y, et al. Front Oncol 2021;11:674933.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cai Z, Chen H, Bai J, Zheng Y, et al. Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer. Front Oncol 2021;11:674933.
PMID: 34041036